Picture of SurModics logo

SRDX SurModics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Surmodics Inc expected to post a loss of 34  cents a share - Earnings Preview

* Surmodics Inc  SRDX.OQ   SRDX.O  is expected to show a
fall in
quarterly revenue when it reports  results on April 27. 
    * The Eden Prairie Minnesota-based  company is expected to
report 
a 31.5% decrease in revenue to $23.975 million from $35 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Surmodics Inc is
for a
loss of 34 cents per share. For the same quarter last year, the
company reported earnings of 62 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Surmodics
Inc is
$68​, above​ its last closing price of $42.06. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.31       -0.31      -0.13     Beat    58.5
 Sep. 30 2021  -0.25       -0.25      -0.10     Beat    60
 Jun. 30 2021  -0.15       -0.17      -0.17     Met     -2​
 Mar. 31 2021  0.66        0.63       0.62      Missed  -2.1
 ​​Dec.        -0.08       -0.09      0.02      Beat    122.2
 31 2020                                                
 Sep. 30 2020  -0.07       -0.08      -0.18     Missed  -125​
 Jun. 30 2020  0.17        0.19       0.21      Beat    8.6
 Mar. 31 2020  -0.13       -0.11      0.04      Beat    137.5
 This summary was machine generated April 25 at 17:07 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on SurModics

See all news